Sofinnova Investments as of Dec. 31, 2020
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 66 positions in its portfolio as reported in the December 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Natera Comm (NTRA) | 18.4 | $309M | 3.1M | 99.52 | |
Karuna Therapeutics Comm | 11.8 | $198M | 2.0M | 101.59 | |
Ascendis Pharma A/S Adr (ASND) | 11.0 | $185M | 1.1M | 166.78 | |
Y-mAbs Therapeutics Comm (YMAB) | 6.5 | $109M | 2.2M | 49.51 | |
United Therapeutics Corp Comm (UTHR) | 3.1 | $53M | 348k | 151.79 | |
Checkmate Pharmaceuticals Comm | 3.1 | $53M | 3.6M | 14.59 | |
AstraZeneca Adr (AZN) | 2.5 | $42M | 843k | 49.99 | |
Inozyme Pharma Comm (INZY) | 2.5 | $42M | 2.0M | 20.64 | |
Amgen Comm (AMGN) | 2.3 | $38M | 165k | 229.92 | |
Jazz Pharmaceuticals Comm (JAZZ) | 2.1 | $35M | 213k | 165.05 | |
Health Care Select Sector SPDR Comm Put Option (XLV) | 2.0 | $34M | 300k | 113.44 | |
Galera Therapeutics Comm (GRTX) | 1.9 | $32M | 3.1M | 10.23 | |
Abbvie Comm (ABBV) | 1.9 | $32M | 294k | 107.15 | |
Akouos Adr | 1.8 | $30M | 1.5M | 19.83 | |
Nextcure Comm | 1.7 | $29M | 2.7M | 10.90 | |
Intra-Cellular Therapies Comm (ITCI) | 1.6 | $27M | 848k | 31.80 | |
iShares Russell 2000 ETF Comm Put Option (IWM) | 1.5 | $26M | 130k | 196.06 | |
Nucana Biomed Adr (NCNA) | 1.5 | $25M | 5.6M | 4.49 | |
Merus Comm (MRUS) | 1.4 | $23M | 1.3M | 17.53 | |
PTC Therapeutics Comm (PTCT) | 1.1 | $19M | 317k | 61.03 | |
Reata Pharmaceuticals Comm | 1.1 | $18M | 149k | 123.62 | |
Athira Pharma Comm (ATHA) | 1.0 | $17M | 509k | 34.25 | |
Otonomy Comm | 1.0 | $17M | 2.6M | 6.47 | |
Horizon Therapeutics Comm | 0.9 | $16M | 213k | 73.15 | |
Protagonist Therapeutics Comm | 0.9 | $15M | 725k | 20.16 | |
Biomarin Pharmaceutical Comm (BMRN) | 0.9 | $14M | 165k | 87.69 | |
Aclaris Therapeutics Comm (ACRS) | 0.7 | $12M | 1.9M | 6.47 | |
Regenxbio Comm (RGNX) | 0.7 | $12M | 271k | 45.36 | |
GW Pharmaceuticals Adr | 0.7 | $12M | 101k | 115.41 | |
Nucana Biomed Ordinary Shares | 0.6 | $11M | 2.4M | 4.49 | |
Cytokinetics Comm (CYTK) | 0.6 | $11M | 508k | 20.78 | |
MacroGenics Comm (MGNX) | 0.6 | $11M | 459k | 22.86 | |
TCR2 Therapeutics Comm | 0.6 | $10M | 334k | 30.93 | |
Insmed Comm (INSM) | 0.6 | $10M | 310k | 33.29 | |
ObsEva SA Comm | 0.6 | $9.9M | 4.7M | 2.08 | |
Arena Pharmaceuticals Comm | 0.6 | $9.3M | 121k | 76.83 | |
Sarepta Therapeutics Comm (SRPT) | 0.5 | $8.8M | 52k | 170.50 | |
ACADIA Pharmaceuticals Comm (ACAD) | 0.5 | $8.8M | 165k | 53.46 | |
BioCryst Pharmaceuticals Comm (BCRX) | 0.5 | $8.4M | 1.1M | 7.45 | |
Syndax Pharmaceuticals Comm (SNDX) | 0.5 | $8.3M | 373k | 22.24 | |
Mirum Pharmaceuticals Comm (MIRM) | 0.5 | $7.9M | 455k | 17.46 | |
Coherus BioSciences Comm (CHRS) | 0.4 | $7.6M | 435k | 17.38 | |
ChemoCentryx Comm | 0.4 | $7.0M | 113k | 61.92 | |
Jounce Therapeutics Comm | 0.4 | $6.5M | 925k | 7.00 | |
Puma Biotechnology Comm (PBYI) | 0.4 | $6.5M | 630k | 10.26 | |
Eli Lilly and Comm (LLY) | 0.4 | $6.2M | 37k | 168.85 | |
Amarin Corp Adr (AMRN) | 0.3 | $5.7M | 1.2M | 4.89 | |
Aligos Therapeutics Comm (ALGS) | 0.3 | $5.3M | 191k | 27.65 | |
Calithera Biosciences Comm | 0.3 | $5.3M | 1.1M | 4.91 | |
Arcus Biosciences Comm (RCUS) | 0.3 | $4.8M | 186k | 25.96 | |
Acceleron Pharma Comm | 0.3 | $4.7M | 37k | 127.94 | |
Iovance Biotherapeutics Comm Put Option (IOVA) | 0.3 | $4.6M | 100k | 46.40 | |
Aptose Biosciences Comm | 0.3 | $4.3M | 981k | 4.38 | |
IGM Biosciences Comm (IGMS) | 0.2 | $4.0M | 45k | 88.30 | |
Kura Oncology Comm (KURA) | 0.2 | $3.9M | 121k | 32.66 | |
TG Therapeutics Comm (TGTX) | 0.2 | $3.4M | 66k | 52.02 | |
Marinus Pharmaceuticals Comm (MRNS) | 0.2 | $3.3M | 274k | 12.20 | |
Immatics NV Comm (IMTX) | 0.2 | $3.0M | 280k | 10.79 | |
Zogenix Comm | 0.1 | $1.8M | 90k | 19.99 | |
Synlogic Comm | 0.1 | $1.2M | 575k | 2.16 | |
Fate Therapeutics Comm (FATE) | 0.1 | $1.2M | 14k | 90.91 | |
Kadmon Holdings Comm | 0.1 | $950k | 229k | 4.15 | |
Replimune Group Comm (REPL) | 0.0 | $763k | 20k | 38.15 | |
Liquidia Corp Comm (LQDA) | 0.0 | $436k | 148k | 2.95 | |
PDS Biotechnology Corporation Comm (PDSB) | 0.0 | $305k | 143k | 2.14 | |
Bioatla Comm (BCAB) | 0.0 | $102k | 3.0k | 34.00 |